Alternatives to Dapoxetine for Premature Ejaculation

Primary Alternatives

The European Association of Urology recommends lidocaine/prilocaine spray or cream as a highly effective alternative to dapoxetine, increasing intravaginal ejaculatory latency time (IELT) up to 6.3-fold over 3 months 1
The American Urological Association suggests that the EMA-approved spray formulation contains lidocaine 150 mg/ml and prilocaine 50 mg/ml, applied 20-30 minutes before intercourse 2, 1
Topical anesthetic agents, such as lidocaine/prilocaine, avoid systemic side effects and are suitable for patients concerned about taking oral medications 3
The main limitation of topical anesthetic agents is local penile hypoesthesia and potential partner numbness, which can be minimized by using a condom or washing the penis thoroughly before penetration 4, 5

The American Urological Association recommends paroxetine 10-40 mg daily as the most effective oral alternative to dapoxetine, producing an 8.8-fold increase in IELT 6, 3
Daily sertraline 50-200 mg and fluoxetine 20-40 mg are also effective options for treating premature ejaculation, as recommended by the American Urological Association 6, 3
Daily SSRI therapy provides more consistent and stronger ejaculatory delay than on-demand dosing, though it requires continuous medication use 3

Tramadol on-demand increases IELT up to 2.5-fold and may be considered for patients who have failed first-line therapies, but use with caution due to opioid-like addiction potential 1, 3
Alpha-1 adrenoreceptor antagonists, such as alfuzosin and terazosin, show modest efficacy in limited studies and should be considered only after failure of first-line therapies 2, 7

Combining behavioral therapy with any pharmacological approach is more effective than either modality alone, with a Moderate Recommendation and Grade B evidence 4, 5
Daily low-dose SSRI plus on-demand dosing may benefit patients with partial response to monotherapy 3
If erectile dysfunction coexists, treat ED first or concomitantly, as some acquired PE may be secondary to ED 1, 3
PDE5 inhibitors combined with SSRIs show superior results to SSRI monotherapy, enhancing confidence and sexual satisfaction 1, 7, 3

Avoid sudden cessation or rapid dose reduction of daily SSRIs to prevent withdrawal syndrome 4, 5
Monitor for serotonin syndrome when combining multiple serotonergic agents, with symptoms including tremor, hyperreflexia, agitation, diaphoresis, and fever 4
No increased suicidal ideation has been found in non-depressed men with PE, but caution is warranted in adolescents and those with comorbid depression 4, 5
Approximately 40% of patients refuse or discontinue SSRI treatment within 12 months due to concerns about taking antidepressants, cost, or treatment effects below expectations 4, 5, 6